top of page
WHAT TO EXPECT
SAFE FOR PROLONGED USE
For prevention of acid reflux or LPR, take Refluxter 15-20 minutes after meals to allow it to work effectively with stomach acid. Avoid taking it before or during meals as it won't work well if food disrupts the raft. Remember, it's crucial to take Refluxter after meals for best results.
For immediate relief of heartburn symptoms, take Refluxter when symptoms occur. For more severe symptoms, you can take an extra capsule if two capsules aren't relieving the heartburn.
Refluxter is an alginate therapy that
harnesses the natural healing ability of kelp.
Alginate is an all-natural polysaccharide
harvested from brown seaweed (kelp) and has
been used safely in the food industry for over
100 years.
Immediate Symptom Relief
Natural and Safe
Protective Action - Protects the esophagus lining from further damage
BEST-IN-CLASS STANDARDS MAKE
REFLUXTER A ONE-OF-A-KIND
SUPPLEMENT
LOOK AS GOOD AS YOU FEEL
PREMIUM PRODUCT
UNIQUE MECHANISM
When Refluxter reaches
your stomach, it forms a protective
gel "raft" that floats on top of your
stomach contents, physically
blocking reflux into the
esophagus. The alginate raft
will last for a few hours,
then dissolve and digest.
Get back to living the life
you love comfortably: jogging,
golfing, or just getting things
done around the house.
Refluxter helps lessen daily
heartburn, indigestion or
discomfort so you can get back
to doing the things you enjoy.
Refluxter has the most amount
of the key ingredient sodium
alginate per serving. The
superstar ingredient alginate
has multifunctional properties
helping with acid reflux,
digestion, and esophageal
support. More of what counts!
Distributed by Nutritist LLC, 207 W Plant St #770935, Winter Garden, FL 34777
Customer Support: support@nutritist.us
WHY REFLUXTER?
The increase in Proton Pump Inhibitor (PPI) usage has called into question the long-term effects of these medications. Some concerns include:
-
Infection, particularly Clostridium difficile and pneumonia
-
Long term use and dementia
-
The interaction with antiplatelet agents
-
The development or progression of chronic kidney disease
NEWS
bottom of page